临床实践
Copyright ©The Author(s) 2024.
世界华人消化杂志. 2024-08-28; 32(8): 584-590
在线出版 2024-08-28. doi: 10.11569/wcjd.v32.i8.584
表1 两组基线资料比较[n(%)]/(mean±SD)
基线资料肺损伤组(n = 56)非肺损伤组(n = 94)t/χ2P
性别
31(55.36)49(52.13)0.1470.701
25(44.64)45(47.87)
年龄(岁)52.69±12.3344.87±10.96b4.032<0.001
BMI(kg/m2)24.24±2.8921.87±2.05b5.858<0.001
发病至入院时间(h)12.57±2.3111.84±3.021.5570.122
吸烟史17(30.36)24(25.53)0.4110.521
饮酒史20(35.71)31(32.98)0.1170.732
基础疾病
糖尿病19(33.93)28(29.79)0.2800.597
冠心病10(17.86)15(15.96)0.0910.763
高血压15(26.79)22(23.40)0.2160.642
胸腔积液
17(30.36)13(13.83)a5.9910.014
39(69.64)81(86.17)
甘油三酯(mmol/L)6.17±1.684.93±1.45b4.772<0.001
病情评分(分)
APACHEⅡ评分24.82±2.2719.82±3.04b10.659<0.001
MCTSI评分6.98±0.256.57±0.14b12.883<0.001
SOFA评分3.52±1.152.01±0.45b11.372<0.001
表2 两组外周血C肽、IL-6及HBP水平比较(mean±SD)
组别例数C肽(ng/mL)IL-6(ng/L)HBP(ng/mL)
肺损伤组560.65±0.1740.85±8.94274.38±54.33
非肺损伤组940.82±0.29b34.82±6.03b206.59±33.97b
t3.9944.9289.408
P<0.001<0.001<0.001
表3 外周血C肽、IL-6及HBP水平与病情评分的相关性
指标APACHEⅡ评分
MCTSI评分
SOFA评分
rPrPrP
C肽-0.574<0.001-0.592<0.001-0.589<0.001
IL-60.602<0.0010.614<0.0010.607<0.001
HBP0.599<0.0010.602<0.0010.605<0.001
表4 HLAP患者肺损伤影响因素的多因素Logistic回归分析
变量βS.E.Wald χ2OR95%CIP
BMI0.4710.1806.8491.6021.257-2.041<0.001
三酰甘油0.5830.2117.6331.7911.332-2.409<0.001
C肽-0.1000.0425.6460.9050.824-0.994<0.001
IL-60.4600.1786.6721.5841.246-2.013<0.001
HBP0.5100.1936.9861.6651.309-2.119<0.001
表5 外周血C肽、IL-6及HBP水平对HLAP患者肺损伤的预测价值
指标AUC(95%CI)Z统计截断值敏感度特异度P
C肽(ng/mL)0.792(0.718-0.854)8.1460.8875.00%73.40%<0.001
IL-6(ng/L)0.794(0.721-0.856)7.23937.3666.07%85.11%<0.001
HBP(ng/mL)0.727(0.649-0.797)5.197254.7566.07%73.40%<0.001
联合预测0.906(0.847-0.947)17.417-89.29%81.91%<0.001

引文著录: 陈园, 汤武亨, 曹春宇, 徐乾超. 高脂血症性胰腺炎患者外周血C肽、IL-6及HBP与肺损伤的相关性探讨. 世界华人消化杂志 2024; 32(8): 584-590